TrialCell stress & chaperones2021

CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients.

M Hernandez-Cedeño et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.